Send and receive information on adverse drug reactions (ADRs)
Imported from official source
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
This version
- Version
- 1 of 1
- Recorded
- September 15, 2026 20:43
- Change
- Initial
- Content hash
72c836ea1d2643046f92ccec47526488- All versions
- Revision history